Ceftaroline fosamil

CAS No. 400827-46-5

Ceftaroline fosamil ( TAK-599,PPI0903 )

Catalog No. M22034 CAS No. 400827-46-5

Ceftaroline fosamil is a cephalosporin,with activity against Gram-positive pathogens.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 115 In Stock
10MG 192 In Stock
25MG 357 In Stock
50MG 560 In Stock
100MG 797 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Ceftaroline fosamil
  • Note
    Research use only, not for human use.
  • Brief Description
    Ceftaroline fosamil is a cephalosporin,with activity against Gram-positive pathogens.
  • Description
    Ceftaroline fosamil is a cephalosporin,with activity against Gram-positive pathogens.Ceftaroline fosamil 600 mg given every 12 h was superior to ceftriaxone 2 g given every 24 h for the treatment of Asian patients with PORT III-IV community-acquired pneumonia. These data suggest that ceftaroline fosamil should be regarded as an alternative to ceftriaxone in empirical treatment regimens for this patient population.
  • Synonyms
    TAK-599,PPI0903
  • Pathway
    GPCR/G Protein
  • Target
    Antibacterial
  • Recptor
    Bacterial;Antibiotic
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    400827-46-5
  • Formula Weight
    744.74
  • Molecular Formula
    C24H25N8O10PS4
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:14 mg/mL (32.22 mM; Need ultrasonic and warming)
  • SMILES
    CCON=C(C1=NSC(=N1)NP(=O)(O)O)C(=O)NC2C3N(C2=O)C(=C(CS3)SC4=NC(=CS4)C5=CC=[N+](C=C5)C)C(=O)O.CC(=O)[O-]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Zhong, Nan Shan, Sun, Tieying, Zhuo, Chao,et,al. Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial[J]. Lancet Infectious Diseases, 2015, 15(2):161-171.
molnova catalog
related products